← Back to Search
Ceramic Nanovector Based On Layered Double Hydroxide: Attributes, Physiologically Relevant Compositions And Surface Activation
S. Dey, R. Sistiabudi
Published 2007 · Materials Science
Download PDFAnalyze on Scholarcy
Abstract Since 2001, intercalated or biohybridised ceramics based on layered double (M2+,M3+) hydroxide nanoparticles (LDHN) have been evaluated as a passive vector for drug and non-viral gene delivery. This paper identifies the attributes of LDHN as a passive delivery platform, judiciously selects and discusses issues in synthesis of physiologically relevant compositions, and demonstrates surface activation of (Mg2+,Al3+) LDHN; the latter a critical first step in the surface functionalisation process for active targeting. After a description of the layered double hydroxide (LDH) structure and unique attributes of LDHN as a passive platform, the advantages and issues of a robust LDHN surface functionalisation process for active targeting are identified. Next, the judicious selection of physiological relevant (Mg2+,Fe3+) and (Zn2+,Fe3+) LDH compositions is made, and their synthesis by precipitation and potential difficulties are discussed. Finally, the surface activation of (Mg2+,Al3+) LDHN is demonstrated by a bimolecular, nucleophilic substitution type reaction using acryloyl chloride.
This paper references
Biomedical applications of nanotechnology--implications for drug targeting and gene therapy.
S. Davis (1997)
Intercalation of Vitamer into LDH and Their Controlled Release Properties
Jin-Ho Choy (2004)
Newer trace elements in nutrition.
W. Mertz (1971)
Preparation method for organic-inorganic layered compounds including fibrous materials by the reaction of Zn(OH)2 with organic compounds
Sumikazu Ogata (1998)
Nanobiohybrids as delivery vehicles for camptothecin.
Katherine M. Tyner (2004)
Layered double hydroxide as an efficient drug reservoir for folate derivatives.
J. Choy (2004)
Magnetic resonance molecular imaging with nanoparticles
G. Lanza (2004)
Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles
A. Morawski (2004)
Inorganic delivery vector for intravenous injection.
Seo-Young Kwak (2004)
Cellular uptake behavior of [γ-32P] labeled ATP–LDH nanohybrids
J. Choy (2001)
Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor
A. Quintana (2004)
Biodegradable nanoparticles — From sustained release formulations to improved site specific drug delivery
J. Leroux (1996)
Ligand-targeted therapeutics in anticancer therapy
T. Allen (2002)
Nanocrystal targeting in vivo
M. Akerman (2002)
Nanosuspensions in drug delivery
Barrett E. Rabinow (2004)
Intercalative route to heterostructured nanohybrids
Jin-Ho Choy (2002)
Synthesis and characterization of layered double hydroxides (LDH) intercalated with non-steroidal anti-inflammatory drugs (NSAID)
M. Arco (2004)
Preparation of 1-hydroxyethylidene-1,1-diphosphonic acid-intercalated layered double hydroxide and its physicochemical properties.
H. Nakayama (2003)
Drug delivery in polymeric micelles: from in vitro to in vivo.
N. Rapoport (2003)
Magnesium Deficiency: A Cause of Heterogenous Disease in Humans
R. Rude (1998)
Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro.
C. Sperling (2004)
Intercalation, delivery, and expression of the gene encoding green fluorescence protein utilizing nanobiohybrids.
Katherine M Tyner (2004)
Bioceramics: From Concept to Clinic
L. Hench (1991)
Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors.
J. Williams (2003)
Dendritic polymer macromolecular carriers for drug delivery.
A. Patri (2002)
Trace element risk assessment: essentiality vs. toxicity.
S. Goldhaber (2003)
Acid fuchsin-interleaved Mg–Al-layered double hydroxide for the formation of an organic–inorganic hybrid nanocomposite
M. Hussein (2004)
Control of molecular polymorphisms by a structured carbohydrate / ceramic delivery vehicle — aquasomes
N. Kossovsky (1996)
Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution.
I. D. Xynos (2001)
In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering.
K. Marra (1999)
Layered double hydroxide stability. 1. Relative stabilities of layered double hydroxides and their simple counterparts.
J. W. Boclair (1999)
Synthesis and Structural Transformations of Hydrotalcite-like Materials Mg-Al and Zn-Al
R. V. Prikhod’ko (2001)
Physical polymer matrices based on affinity interactions between peptides and polysaccharides.
Brandon L Seal (2003)
Coprecipitated nickel–alumina catalysts for methanation at high temperature. Part 2.—Variation of total and metallic areas as a function of sample composition and method of pretreatment
L. Alzamora (1981)
The metabolic and molecular basis of acquired disease
R. Cohen (1990)
Effect of hydrotalcite on the physical properties and drug-release behavior of nanocomposite hydrogels based on poly[acrylic acid-co-poly(ethylene glycol) methyl ether acrylate] gels
W. Lee (2004)
Preparation of Layered Double-Hydroxide Nanomaterials with a Uniform Crystallite Size Using a New Method Involving Separate Nucleation and Aging Steps
Y. Zhao (2002)
Development of hemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer.
A. Khopade (2002)
Hydrotalcite-type anionic clays: Preparation, properties and applications.
F. Cavani (1991)
C1-C6 Alcohols from synthesis gas on copper-cobalt catalysts
P. Courty (1982)
Bio-LDH nanohybrid for gene therapy
Seo-Young Kwak (2002)
Intercalative route to heterostructured nanohybrid
Jin-Ho Choy (2004)
Preparation and intercalation chemistry of magnesium–iron(III) layered double hydroxides containing exchangeable interlayer chloride and nitrate ions
W. Meng (2004)
In vitro release of citrate anions intercalated in magnesium aluminium layered double hydroxides
Jairo Tronto (2004)
Chemistry for peptide and protein PEGylation.
M. Roberts (2002)
Tumor Therapy with Targeted Atomic Nanogenerators
M. McDevitt (2001)
Synthesis of hydrotalcite-like compounds and their physico-chemical properties
T. Sato (1988)
Alcohol formation from synthesis gas: A thermodynamic study
A. Marchi (1986)
Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules.
V. Mosqueira (2001)
Synthesis of anionic clay minerals (mixed metal hydroxides, hydrotalcite)
W. T. Reichle (1986)
A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes.
K. Sagara (2002)
CRC Handbook of Chemistry and Physics
D. Lide (1996)
Studies on the intercalation of naproxen into layered double hydroxide and its thermal decomposition by in situ FT-IR and in situ HT-XRD
M. Wei (2004)
Mg,Al layered double hydroxides with intercalated indomethacin: synthesis, characterization, and pharmacological study.
M. del Arco (2004)
Methods for targeting biologicals to specific disease sites.
A. Nissim (2004)
Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety.
I. Kim (2003)
Nanotech approaches to drug delivery and imaging.
S. Sahoo (2003)
New Synthetic Routes to Hydrotalcite-Like Compounds − Characterisation and Properties of the Obtained Materials
U. Costantino (1998)
Function and regulation of transferrin and ferritin.
P. Ponka (1998)
Preparation of New Useful Materials by Surface Modification of Inorganic Layered Compound
H. Morioka (1995)
Third-Generation Biomedical Materials
L. Hench (2002)
Casarett and Doull's toxicology : the basic science of poisons :companion handbook
Louis J. Casarett (1999)
Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits.
V. Awasthi (2003)
Organic Anions of Pharmaceutical Interest Intercalated in Magnesium Aluminum LDHs by Two Different Methods
J. Tronto (2001)
Infrared and Raman study of interlayer anions CO32–, NO3–, SO42– and ClO4– in Mg/Al-hydrotalcite
J. T. Kloprogge (2002)
“Smart” polymeric nanospheres as new materials for possible biomedical applications
Krzysztof Szczubiałka (2003)
Iron metabolism: Physiology and pathophysiology
P. Ponka (2000)
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
Identification of rapid changes at plasma-solid interfaces.
L. Vroman (1969)
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.
D. Richardson (1997)
Bio-Resorbable Nanoceramics for Gene and Drug Delivery
W. Kriven (2004)
Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging.
M. Hughes (2005)
Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1
Gen He (2003)
Intercalation chemistry of layered double hydroxides: recent developments and applicationsBasis of a presentation given at Materials Discussion No. 5, 22???25 September 2002, Madrid, Spain.
A. I. Khan (2002)
Effect op the preparation conditions on the reducibility of Cu-Co based oxides
A. Marchi (1992)
Small-scale systems for in vivo drug delivery
David A. LaVan (2003)
Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents--I. Intercalation and in vitro release of ibuprofen.
V. Ambrogi (2001)
This paper is referenced by
Layered double hydroxide nanoparticles in gene and drug delivery
Katharina Ladewig (2009)
Inorganic nanoparticles for cancer imaging and therapy.
Huang-Chiao Huang (2011)
Layereddoublehydroxide nanoparticlesingeneanddrug delivery
Katharina Ladewig (2009)
Synthesis and Characterization of Silver (Core)/Layered Double Hydroxides (Shell) Nanoparticles
W. Noh (2012)
Insights into the synthesis of layered double hydroxide (LDH) nanoparticles: Part 1. Optimization and controlled synthesis of chloride-intercalated LDH.
Xiaodi Sun (2015)
Chemical Processing Science of Ceramic Nanoparticles and Films for Biomedicine and Energy
Sun Zhou (2014)
WITHDRAWN: Inorganic nanoparticles for cancer imaging and therapy.
Huang-Chiao Huang (2011)
Layered double hydroxides as drug carriers and for controlled release of non-steroidal antiinflammatory drugs (NSAIDs): a review.
V. Rives (2013)
The Synthesis and Characterization of Gold-Core/LDH-Shell Nanoparticles
Colton Rearick (2011)
Investigation of Mechanical Properties of Nano Sized Clay/LDH Particle as Hybrid Nano Composite Material
S. Sivasaravanan (2015)
Applications of nanobioceramics to healthcare technology
J. Feng (2013)
Layered double hydroxide and sulindac coiled and scrolled nanoassemblies for storage and drug release
M. A. Rocha (2016)
Modified drug release system based on Sulindac and layered double hydroxide: An in vivo Raman investigation ☆
O. Gil (2016)